Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kitai M"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Kinetics of Glucoregulatory Peptide Hormones during Hemodialysis with Cellulose Triacetate and Polysulfone Dialyzers in Patients with Diabetes and End-Stage Kidney Disease.
Autorzy:
Takao N; Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Itabashi City, Tokyo 173-8610, Japan.
Maruyama T; Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Itabashi City, Tokyo 173-8610, Japan.
Kobayashi H; Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Itabashi City, Tokyo 173-8610, Japan.
Kitai M; Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Itabashi City, Tokyo 173-8610, Japan.
Yoshida Y; Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Itabashi City, Tokyo 173-8610, Japan.
Takashima H; Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Itabashi City, Tokyo 173-8610, Japan.
Abe M; Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Itabashi City, Tokyo 173-8610, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 25; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 25.
Typ publikacji:
Journal Article
MeSH Terms:
Kidney Failure, Chronic*/therapy
Diabetes Mellitus*
Humans ; Animals ; Cattle ; Renal Dialysis ; Glucagon ; Kinetics ; Insulin ; Insulin, Regular, Human ; Membranes, Artificial
Czasopismo naukowe
Tytuł:
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
Autorzy:
Nagao S; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan. .
Kogiku A; Department of Obstetrics and Gynecology, Nishi Kobe Medical Center, 5-7-7-1 Kojidai, Kobe-city, Nishi-ku, 651-2273, Japan.
Suzuki K; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Shibutani T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Yamamoto K; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Jimi T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Kitai M; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Shiozaki T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Matsuoka K; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Yamaguchi S; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2020 Feb 07; Vol. 13 (1), pp. 14. Date of Electronic Publication: 2020 Feb 07.
Typ publikacji:
Clinical Trial, Phase II; Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Fallopian Tube Neoplasms/*drug therapy
Ovarian Neoplasms/*drug therapy
Peritoneal Neoplasms/*drug therapy
Aged ; Bevacizumab/administration & dosage ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Fallopian Tube Neoplasms/pathology ; Female ; Humans ; Middle Aged ; Ovarian Neoplasms/pathology ; Peritoneal Neoplasms/pathology ; Gemcitabine
Czasopismo naukowe
Tytuł:
Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: a randomized controlled trial.
Autorzy:
Maruyama T; Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Maruyama N; Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Higuchi T; Department of Nephrology, Keiai Hospital, Tokyo, Japan.
Nagura C; Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Takashima H; Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Kitai M; Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Utsunomiya K; Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Tei R; Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Furukawa T; Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Yamazaki T; Department of Nephrology, Keiai Hospital, Tokyo, Japan.
Okawa E; Department of Nephrology, Keiai Hospital, Tokyo, Japan.
Ando H; Department of Cardiology, Keiai Hospital, Tokyo, Japan.
Kikuchi F; Department of Nephrology, Meirikai Chuo General Hospital, Tokyo, Japan.
Abe M; Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan. .
Pokaż więcej
Źródło:
European journal of clinical nutrition [Eur J Clin Nutr] 2019 Feb; Vol. 73 (2), pp. 293-301. Date of Electronic Publication: 2018 Oct 23.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Kidney Failure, Chronic*
Renal Dialysis*
Cardiomyopathies/*prevention & control
Carnitine/*deficiency
Carnitine/*therapeutic use
Hyperammonemia/*prevention & control
Muscular Diseases/*prevention & control
Protein-Energy Malnutrition/*prevention & control
Activities of Daily Living ; Adult ; Aged ; Aged, 80 and over ; Body Composition ; Carnitine/administration & dosage ; Dietary Supplements ; Female ; Humans ; Japan ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome ; Young Adult
SCR Disease Name:
Systemic carnitine deficiency
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies